查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613158

全球連續生物加工市場（按產品、製程、應用、營運規模和最終用戶）：未來預測（2025-2030）

Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年連續生物加工市場價值為2.3344億美元，預計到2024年將達到2.8242億美元，複合年成長率為21.30%，到2030年將達到9.0223億美元。

連續生物加工代表了生物技術和製藥行業的一種先進製造方法，旨在透過整合連續流和反饋控制系統來提高效率、產量和成本效益。傳統上依賴大量處理的產業指出，需要在生技藥品（包括單株抗體和重組蛋白）的生產中大力應用連續生物處理。它的使用對於滿足對生技藥品日益成長的需求、同時保持品質和縮短生產時間至關重要。最終用途包括製藥公司、契約製造組織和生物製藥研究設施。

主要市場統計
基準年[2023] 2.3344億美元
預計年份 [2024] 2.8242億美元
預測年份 [2030] 9.0223億美元
複合年成長率（%） 21.30%

市場成長受到生技藥品需求增加、對更有效率、更靈活的製造流程的需求以及一次性技術和自動化技術進步等因素的顯著影響。關鍵機會是個人化醫療和生物相似藥的興起，其中連續的生物過程可以提供擴充性和適應性。鼓勵公司投資開發將批量加工和連續加工相結合的混合模式，以提高生產靈活性。

然而，這個市場面臨初始設置成本高、監管挑戰以及缺乏熟練專業人員等限制。這些因素可能會阻止小型企業採用這些技術。此外，標準化和檢驗流程需要大量的努力和投資。

連續生物加工的創新可以集中於增強製程分析技術（PAT）和即時品管監控。開發穩健、可擴展的一次性系統和完全整合的連續下游加工模組是一個成熟的研發領域，可顯著降低營運成本和環境影響。此外，產業領導者、學術機構和監管機構之間的合作對於簡化監管途徑和加速技術接受至關重要。整體而言，連續生物加工市場充滿活力，具有巨大的成長潛力，因此需要企業對研發和夥伴關係進行策略性投資，以利用新興趨勢，同時克服現有障礙。

市場動態：快速發展的連續生物加工市場的關鍵市場洞察

供需的動態交互作用正在改變連續生物加工市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 生物製藥需求不斷成長以及政府對該行業的支持
    • 批次和一次性技術帶來的更多好處
    • 工業4.0的到來以及自動化數位化的趨勢
  • 市場限制因素
    • 連續生物加工的嚴格法規和高昂的設備成本
  • 市場機會
    • 與一次性設備結合使用灌注
    • 開發基質細胞生產的連續生物製程方法
  • 市場挑戰
    • 操作困難和流程變更問題

波特五力：駕馭連續生物加工市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。它為評估公司的競爭力和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解連續生物加工市場的外部影響

外部宏觀環境因素在塑造連續生物加工市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解連續生物製程市場的競爭格局

對連續生物加工市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：連續生物加工市場供應商的績效評估

FPNV定位矩陣是評估連續生物加工市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：在連續生物加工市場中製定成功之路

對於旨在加強其在全球市場的影響力的公司來說，連續生物加工市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析最近的產品發布、開拓的地區、關鍵產業進展以及塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1. 目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3. 塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 哪些收益來源和策略機會推動供應商的進入/退出策略？

目錄

第1章簡介

第2章 分析方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物製藥需求增加以及政府對該行業的支持
      • 採用批量處理和一次性技術帶來的更多好處
      • 工業4.0的到來以及自動化數位化的趨勢
    • 抑制因素
      • 連續生物加工的嚴格法規和高設備成本
    • 機會
      • 採用與一次性設備結合的灌注
      • 開發用於基質細胞生產的連續生物製程方法
    • 任務
      • 操作困難和流程變更問題
  • 市場區隔分析
    • 產品：反應器在大規模重組蛋白生產中日益普及
    • 流程：由於效率和產能的提高，上游流程的使用增加
    • 應用：透過在疫苗產業廣泛使用連續生物製程來改善公眾健康
    • 營運規模：擴大連續生物加工在臨床業務的應用
    • 最終用戶：連續生物加工發揮關鍵作用，因為 CDMO 優先考慮靈活性和增強的客戶服務。
  • 波特五力分析
  • PESTEL分析
    • 政治因素
    • 經濟因素
    • 社會因素
    • 技術因素
    • 法律因素
    • 環境因素

第6章連續生物加工市場：依產品

  • 反應器
  • 細胞培養基和試劑
  • 離心機
  • 層析法系統
  • 過濾系統
  • 培養箱和搖床

第7章連續生物加工市場：依製程分類

  • 下游生物過程
  • 上游工程生物程序

第8章連續生物加工市場：依應用分類

  • 細胞/基因治療
  • 單株抗體
  • 疫苗

第9章連續生物加工市場：依營運規模

  • 臨床操作
  • 商業運作

第10章連續生物加工市場：依最終用戶分類

  • 學術研究所
  • 合約開發和製造組織
  • 製藥和生物技術公司

第11章美洲連續生物處理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太連續生物加工市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的連續生物加工市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • 藥明生物已成功實施了完全整合的連續工藝，中試規模的生產率突破了約 6 克/公升/天。
    • Sartorius 和 Repligen 推出整合式反應器系統
    • 3M投資約1.5億美元提升生物製藥過濾技術能力
  • 戰略分析和建議

公司名單

  • 3D Biotek LLC
  • 3M Company
  • Adolf Kuhner AG
  • bbi-biotech GmbH
  • Belach Bioteknik AB
  • Bio-Rad Laboratories, Inc.
  • Bionet Servicios Tecnicos SL
  • Colder Products Company
  • Danaher Corporation
  • Esco Aster Pte Ltd.
  • Esco VacciXcell
  • FiberCell Systems Inc.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • GEA Group
  • Getinge AB
  • Infors AG
  • Merck KGaA
  • Repligen Corporation
  • Sartorius AG
  • simAbs NV
  • Suzhou Transcenta Therapeutics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Group
  • WuXi Biologics Co., Ltd.
Product Code: MRR-033F7A232457

The Continuous Bioprocessing Market was valued at USD 233.44 million in 2023, expected to reach USD 282.42 million in 2024, and is projected to grow at a CAGR of 21.30%, to USD 902.23 million by 2030.

Continuous bioprocessing represents an advanced manufacturing approach within the biotechnology and pharmaceuticals industries, aiming to improve efficiency, production yield, and cost-effectiveness by integrating continuous flow and feedback control systems. Traditionally reliant on batch processing, the industry has noted the necessity for continuous bioprocessing due to its robust application in biologics manufacturing, including monoclonal antibodies and recombinant proteins. Its use is critical in meeting growing demand for biologics while maintaining quality and reducing production timelines. The end-use scope spans pharmaceutical companies, contract manufacturing organizations, and biopharmaceutical research facilities.

KEY MARKET STATISTICS
Base Year [2023] USD 233.44 million
Estimated Year [2024] USD 282.42 million
Forecast Year [2030] USD 902.23 million
CAGR (%) 21.30%

Market growth is notably influenced by factors such as increasing demand for biologics, the need for more efficient and flexible manufacturing processes, and technological advancements in single-use technologies and automation. Key opportunities arise from the rise of personalized medicine and biosimilar drugs, where continuous bioprocessing can provide scalability and adaptability. Companies are encouraged to invest in developing hybrid models combining both batch and continuous processing for enhanced production agility.

However, the market faces limitations, including high initial setup costs, regulatory challenges, and a lack of skilled professionals. These factors can deter small and mid-sized enterprises from adopting these technologies. Additionally, standardization and validation of processes require significant effort and investment.

Innovations in continuous bioprocessing could focus on enhancing process analytical technology (PAT) and real-time monitoring for quality control. Development of robust and scalable single-use systems and fully integrated continuous downstream processing modules are areas ripe for research and development that could significantly reduce operational costs and environmental impact. Furthermore, collaboration between industry leaders, academic institutions, and regulatory bodies is crucial to streamline regulatory pathways and accelerate technology acceptance. Overall, the market for continuous bioprocessing is dynamic and holds substantial growth potential, inviting companies to strategically invest in R&D and partnerships to capitalize on emerging trends while navigating existing obstacles.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Bioprocessing Market

The Continuous Bioprocessing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for biopharmaceuticals & government support for the industry
    • Increased benefits over batch processing & uptake of single-use technology
    • Advent of industry 4.0 & trend towards automation & digitization
  • Market Restraints
    • Strict regulations for continuous bioprocessing coupled with high equipment cost
  • Market Opportunities
    • Adoption of perfusion associated with single-use equipment
    • Development of a continuous bioprocessing approach to stromal cell manufacturing
  • Market Challenges
    • Issues with operational difficulties and process changes

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Bioprocessing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Bioprocessing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Bioprocessing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Bioprocessing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Bioprocessing Market

A detailed market share analysis in the Continuous Bioprocessing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Bioprocessing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Bioprocessing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Continuous Bioprocessing Market

A strategic analysis of the Continuous Bioprocessing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, 3M Company, Adolf Kuhner AG, bbi-biotech GmbH, Belach Bioteknik AB, Bio-Rad Laboratories, Inc., Bionet Servicios Tecnicos S.L., Colder Products Company, Danaher Corporation, Esco Aster Pte Ltd., Esco VacciXcell, FiberCell Systems Inc., Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GEA Group, Getinge AB, Infors AG, Merck KGaA, Repligen Corporation, Sartorius AG, simAbs NV, Suzhou Transcenta Therapeutics Co., Ltd., Thermo Fisher Scientific Inc., Watson-Marlow Fluid Technology Group, and WuXi Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Continuous Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bioreactors, Cell Culture Media & Reagent, Centrifuges, Chromatography System, Filtration Systems, and Incubators & Shakers.
  • Based on Process, market is studied across Downstream Bioprocess and Upstream Bioprocess.
  • Based on Application, market is studied across Cell & Gene Therapy, Monoclonal Antibodies, and Vaccines.
  • Based on Scale of Operation, market is studied across Clinical Operations and Commercial Operations.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Development & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biopharmaceuticals & government support for the industry
      • 5.1.1.2. Increased benefits over batch processing & uptake of single-use technology
      • 5.1.1.3. Advent of industry 4.0 & trend towards automation & digitization
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations for continuous bioprocessing coupled with high equipment cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of perfusion associated with single-use equipment
      • 5.1.3.2. Development of a continuous bioprocessing approach to stromal cell manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with operational difficulties and process changes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for bioreactors in large-scale production of recombinant proteins
    • 5.2.2. Process: Rising usage of upstream processes owing to progress in terms of efficiency and capacity
    • 5.2.3. Application: Extensive utilization of continuous bioprocessing in the vaccine industry to improve public health
    • 5.2.4. Scale of Operation: Growing application of continuous bioprocessing in the clinical operations
    • 5.2.5. End-User: Significant role of continuous bioprocessing in CDMO as they prioritize flexibility and service offering enhancements for their clients
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continuous Bioprocessing Market, by Product

  • 6.1. Introduction
  • 6.2. Bioreactors
  • 6.3. Cell Culture Media & Reagent
  • 6.4. Centrifuges
  • 6.5. Chromatography System
  • 6.6. Filtration Systems
  • 6.7. Incubators & Shakers

7. Continuous Bioprocessing Market, by Process

  • 7.1. Introduction
  • 7.2. Downstream Bioprocess
  • 7.3. Upstream Bioprocess

8. Continuous Bioprocessing Market, by Application

  • 8.1. Introduction
  • 8.2. Cell & Gene Therapy
  • 8.3. Monoclonal Antibodies
  • 8.4. Vaccines

9. Continuous Bioprocessing Market, by Scale of Operation

  • 9.1. Introduction
  • 9.2. Clinical Operations
  • 9.3. Commercial Operations

10. Continuous Bioprocessing Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Development & Manufacturing Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Continuous Bioprocessing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Bioprocessing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Bioprocessing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale
    • 14.3.2. Sartorius and Repligen Launch Integrated Bioreactor System
    • 14.3.3. 3M To Invest Nearly USD 150 Million To Advance Capabilities In Biopharma Filtration Technology
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Biotek LLC
  • 2. 3M Company
  • 3. Adolf Kuhner AG
  • 4. bbi-biotech GmbH
  • 5. Belach Bioteknik AB
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bionet Servicios Tecnicos S.L.
  • 8. Colder Products Company
  • 9. Danaher Corporation
  • 10. Esco Aster Pte Ltd.
  • 11. Esco VacciXcell
  • 12. FiberCell Systems Inc.
  • 13. Fujifilm Holdings Corporation
  • 14. GE HealthCare Technologies Inc.
  • 15. GEA Group
  • 16. Getinge AB
  • 17. Infors AG
  • 18. Merck KGaA
  • 19. Repligen Corporation
  • 20. Sartorius AG
  • 21. simAbs NV
  • 22. Suzhou Transcenta Therapeutics Co., Ltd.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Watson-Marlow Fluid Technology Group
  • 25. WuXi Biologics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS BIOPROCESSING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS BIOPROCESSING MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CLINICAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023